BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9844050)

  • 1. Dynamics of serum cytokines in patients with visceral leishmaniasis and HIV-1 co-infection.
    Medrano FJ; Rey C; Leal M; Cañavate C; Rubio A; Sánchez-Quijano A; Alvar J; Lissen E
    Clin Exp Immunol; 1998 Dec; 114(3):403-7. PubMed ID: 9844050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum chemokine profiles in visceral leishmaniasis, HIV and HIV/ visceral leishmaniasis co-infected Ethiopian patients.
    Sisay Z; Berhe N; Petros B; Tegbaru B; Messele T; Hailu A; Wolday D
    Ethiop Med J; 2011 Jul; 49(3):179-86. PubMed ID: 21991751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 inhibits Leishmania-induced cell proliferation but not production of interleukin-6 and tumour necrosis factor alpha.
    Wolday D; Akuffo H; Britton S; Hathaway A; Sander B
    Scand J Immunol; 1994 Apr; 39(4):380-6. PubMed ID: 8146597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre- & post-treatment evaluation of immunological features in Indian visceral leishmaniasis (VL) patients with HIV co-infection.
    Sinha PK; Bimal S; Singh SK; Pandey K; Gangopadhyay DN; Bhattacharya SK
    Indian J Med Res; 2006 Mar; 123(3):197-202. PubMed ID: 16778304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection.
    Peruhype-Magalhães V; Martins-Filho OA; Prata A; Silva Lde A; Rabello A; Teixeira-Carvalho A; Figueiredo RM; Guimarães-Carvalho SF; Ferrari TC; Van Weyenbergh J; Correa-Oliveira R
    Clin Exp Immunol; 2006 Oct; 146(1):124-32. PubMed ID: 16968407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher levels of TNF and IL-4 cytokines and low miR-182 expression in visceral leishmaniasis-HIV co-infected patients.
    Barbosa Júnior WL; Justo AM; Aguiar Dos Santos AM; de Lorena VMB; do Carmo RF; de Melo FL; de Medeiros ZM; Vasconcelos LRS
    Parasite Immunol; 2020 Apr; 42(4):e12701. PubMed ID: 31990371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of circulating levels of interferon-gamma, interleukin-10 and tumor necrosis factor-alpha in patients with visceral leishmaniasis.
    de Medeiros IM; Castelo A; Salomão R
    Rev Inst Med Trop Sao Paulo; 1998; 40(1):31-4. PubMed ID: 9713135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic immunosuppression by candida in HIV infection: a cytokine based analysis.
    Bajaj JS; Singh A; Aggarwal SK; Chattopadhya D; Baveja UK
    J Commun Dis; 2000 Mar; 32(1):1-9. PubMed ID: 11186879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines and visceral leishmaniasis: a comparison of plasma cytokine profiles between the clinical forms of visceral leishmaniasis.
    Costa AS; Costa GC; Aquino DM; Mendonça VR; Barral A; Barral-Netto M; Caldas Ade J
    Mem Inst Oswaldo Cruz; 2012 Sep; 107(6):735-9. PubMed ID: 22990961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological factors, but not clinical features, predict visceral leishmaniasis relapse in patients co-infected with HIV.
    Takele Y; Mulaw T; Adem E; Shaw CJ; Franssen SU; Womersley R; Kaforou M; Taylor GP; Levin M; Müller I; Cotton JA; Kropf P
    Cell Rep Med; 2022 Jan; 3(1):100487. PubMed ID: 35106507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis.
    Kumar V; Bimal S; Singh SK; Chaudhary R; Das S; Lal C; Pandey K; Das VR; Das P
    Nutrition; 2014 Apr; 30(4):449-58. PubMed ID: 24607302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma and tumour necrosis factor-alpha production by CD4+ T and CD8+ T lymphocytes in AIDS patients with tuberculosis.
    de Castro Cunha RM; Kallas EG; Rodrigues DS; Nascimento Burattini M; Salomao R
    Clin Exp Immunol; 2005 Jun; 140(3):491-7. PubMed ID: 15932510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined neutralization of interferon gamma and tumor necrosis factor alpha induces IL-4 production but has no direct additive impact on parasite burden in splenic cultures of human visceral leishmaniasis.
    Singh N; Sundar S
    PLoS One; 2018; 13(6):e0199817. PubMed ID: 29953494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral leishmaniosis in HIV-positive patients: primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphocyte counts.
    Kubar J; Marty P; Lelièvre A; Quaranta JF; Staccini P; Caroli-Bosc C; Le Fichoux Y
    AIDS; 1998 Nov; 12(16):2147-53. PubMed ID: 9833855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell subset and cytokine profiles in human visceral leishmaniasis during active and asymptomatic or sub-clinical infection with Leishmania donovani.
    Hailu A; van Baarle D; Knol GJ; Berhe N; Miedema F; Kager PA
    Clin Immunol; 2005 Nov; 117(2):182-91. PubMed ID: 16125466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of serum cytokine levels in symptomatic and asymptomatic HIV-Leishmania coinfected individuals from a Brazilian visceral leishmaniasis endemic area.
    Guedes DL; Silva EDD; Castro MCAB; Júnior WLB; Ibarra-Meneses AV; Tsoumanis A; Adriaensen W; van Griensven J; Pereira VRA; Medeiros ZM
    PLoS Negl Trop Dis; 2022 Jun; 16(6):e0010542. PubMed ID: 35714136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis.
    Caldas A; Favali C; Aquino D; Vinhas V; van Weyenbergh J; Brodskyn C; Costa J; Barral-Netto M; Barral A
    BMC Infect Dis; 2005 Dec; 5():113. PubMed ID: 16364177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CYTOKINES DURING THE HUMAN IMMUNODEFICIENCY VIRUS INFECTION TYPE 1(HIV-1)].
    Selimova LM; Kalnina LB; Serebrovskaya LV; Ivanova LA; Gulyaeva AN; Nosik DN
    Vopr Virusol; 2016; 61(1):39-41. PubMed ID: 27145600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral leishmaniasis in those infected with HIV: clinical aspects and other opportunistic infections.
    Russo R; Laguna F; López-Vélez R; Medrano FJ; Rosenthal E; Cacopardo B; Nigro L
    Ann Trop Med Parasitol; 2003 Oct; 97 Suppl 1():99-105. PubMed ID: 14678637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis.
    Hailu A; van der Poll T; Berhe N; Kager PA
    Am J Trop Med Hyg; 2004 Nov; 71(5):561-7. PubMed ID: 15569785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.